Repository

Publications

Parenteral Berberine vs Cisplatin- Loaded Lipid Nanoparticles - Development, Characterisation, Comparative Safety Profiling and Cytotoxicity in Cholangiocarcinoma Cell Models

Manov M, Stefanova D, Tzankova V, Tzankov B, Lozano E, Delgado-Calvo K, Macias RIR, Marin JJG, Spassova I, Kovacheva D, Slavkova M
Nanotechnol Sci Appl. 2026 May 20;19:596038. doi: 10.2147/NSA.S596038
2026 
Result from  
Funded by  

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study

Vandeputte H, Casadei-Gardini A, Peeters F, Rimini M, Nichetti F, Saborowski A, Antonuzzo L, Passeri L, Satake T, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Corallo S, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Qaisar A, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Lancianese A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Couto N, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Alvim CM, Roque R, Farinea G, De Rosa A, Lanzetta I, Balsano R, Lavacchi D, Camera S, Ikeda M, Niger M, Tesini G, Tonini G, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Ferrara M, Lo Prinzi F, Himmelsbach V, Landriscina M, Djaballah SA, Persano M, Salani F, Vogel A, Lonardi S, Fornaro L, Rimassa L, Dekervel J.
ESMO Gastrointest Oncol. 2026 May 8;12:100335. doi: 10.1016/j.esmogo.2026.100335
2026 
Result from  

IDH1 R132 mutations or HER2-positivity and benefit from platinum-based therapy for biliary tract cancers

Tesini G, Greaves J, Knight O, Shand H, Ammirabile A, McHaffie S, Milne J, Ibrahim H, Meenan R, Campbell S, Henderson M, Lampis A, Chesler L, Casadei-Gardini A, Rimassa L, Christie A, Kendall TJ, Braconi C
JHEP Rep. 2026 May 20:101899. doi: 10.1016/j.jhepr.2026.101899
2026 
Result from  
Funded by  

Metagenomic profiling of bile in malignant cholestasis: Analysis of samples collected during EUS-guided biliary drainage

Krupa L, Schmarz GP, Staron R, Schmidt HH, Rehner J, Becker SL, Krawczyk M
Eur J Clin Invest. 2026 May;56(5):e70200. doi: 10.1111/eci.70200.
2026 
Result from  

MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth

Agirre-Lizaso A, Huici-Izagirre M, O'Rourke CJ, Zhuravleva E, Carpino G, Overi D, Urretabizkaia-Garmendia J, Labiano I, Korosec A, Val B, Calvisi DF, Ilyas SI, den Haan JMM, Aspichueta P, Hijona E, La Casta A, Jiménez-Agüero R, Lleo A, Macias RIR, Gaudio E; European CCA Histology Registry; Andersen JB, Schabbauer G, Bujanda L, Rodrigues PM, Sharif O, Banales JM, Perugorria MJ.
Signal Transduct Target Ther. 2026 Apr 29;11(1):158. doi: 10.1038/s41392-026-02657-w
2026 
Result from  
OA Funded by  
Join the Action
JOIN